A leading global supplier and manufacturer of critical raw materials for life sciences. Specialists in fine chemicals, peptides and key biologics for pharma and diagnostics.
Location: Switzerland, St. Gallen, Staad
Employees: 201-500
Founded date: 1966
Investors 2
| Date | Name | Website |
| 02.12.2022 | BroadOak C... | broadoak.c... |
| 04.03.2023 | Kohlberg K... | kkr.com |
Mentions in press and media 3
| Date | Title | Description | Source |
| 29.12.2023 | Biosynth acquires Zurich-based VIO Chemicals | Biosynth, a supplier of critical raw materials to the life science industry, has acquired VIO Chem... | startuptic... |
| 11.07.2023 | celares GmbH Sells to Biosynth | BroadOak Capital Partners advised Biosynth on the acquisition of celares GmbH. Celares provides cust... | broadoak.c... |
| 07.01.2019 | NEMIS Technologies raises CHF3 million in a seed round | Pathogenic microorganisms like bacteria and fungi are a rapidly emerging, major threat to human, a... | startuptic... |